Global KRAS G12C Inhibitors Market Growth 2026-2032
The global KRAS G12C Inhibitors market size is predicted to grow from US$ 359 million in 2025 to US$ 5529 million in 2032; it is expected to grow at a CAGR of 48.8% from 2026 to 2032.
KARC G12C inhibitors are targeted therapeutics for G12C mutation, a specific mutation in the KRAS gene. KRAS gene mutations are prevalent in a variety of cancers, particularly in non-small cell lung cancer (NSCLC), where G12C mutations are a common driver. Its mechanism of action is to form covalent bonds with cysteine residues of the KRAS G12C mutant protein, locking KRAS in its inactive conformation and blocking its signaling, thereby inhibiting the proliferation of tumor cells. The development of this class of drugs offers a new therapeutic avenue for cancer patients carrying the KRAS G12C mutation, especially for those who are not sensitive to conventional chemotherapy.
United States market for KRAS G12C Inhibitors is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for KRAS G12C Inhibitors is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for KRAS G12C Inhibitors is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key KRAS G12C Inhibitors players cover Amgen, Innovent Biologics, Inc., Mirati Therapeutics, Genfleet Therapeutics (Shanghai), Inc., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the ?KRAS G12C Inhibitors Industry Forecast? looks at past sales and reviews total world KRAS G12C Inhibitors sales in 2025, providing a comprehensive analysis by region and market sector of projected KRAS G12C Inhibitors sales for 2026 through 2032. With KRAS G12C Inhibitors sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world KRAS G12C Inhibitors industry.
This Insight Report provides a comprehensive analysis of the global KRAS G12C Inhibitors landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on KRAS G12C Inhibitors portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global KRAS G12C Inhibitors market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for KRAS G12C Inhibitors and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global KRAS G12C Inhibitors.
This report presents a comprehensive overview, market shares, and growth opportunities of KRAS G12C Inhibitors market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global KRAS G12C Inhibitors market?
What factors are driving KRAS G12C Inhibitors market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do KRAS G12C Inhibitors market opportunities vary by end market size?
How does KRAS G12C Inhibitors break out by Type, by Application?
KARC G12C inhibitors are targeted therapeutics for G12C mutation, a specific mutation in the KRAS gene. KRAS gene mutations are prevalent in a variety of cancers, particularly in non-small cell lung cancer (NSCLC), where G12C mutations are a common driver. Its mechanism of action is to form covalent bonds with cysteine residues of the KRAS G12C mutant protein, locking KRAS in its inactive conformation and blocking its signaling, thereby inhibiting the proliferation of tumor cells. The development of this class of drugs offers a new therapeutic avenue for cancer patients carrying the KRAS G12C mutation, especially for those who are not sensitive to conventional chemotherapy.
United States market for KRAS G12C Inhibitors is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for KRAS G12C Inhibitors is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for KRAS G12C Inhibitors is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key KRAS G12C Inhibitors players cover Amgen, Innovent Biologics, Inc., Mirati Therapeutics, Genfleet Therapeutics (Shanghai), Inc., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the ?KRAS G12C Inhibitors Industry Forecast? looks at past sales and reviews total world KRAS G12C Inhibitors sales in 2025, providing a comprehensive analysis by region and market sector of projected KRAS G12C Inhibitors sales for 2026 through 2032. With KRAS G12C Inhibitors sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world KRAS G12C Inhibitors industry.
This Insight Report provides a comprehensive analysis of the global KRAS G12C Inhibitors landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on KRAS G12C Inhibitors portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global KRAS G12C Inhibitors market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for KRAS G12C Inhibitors and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global KRAS G12C Inhibitors.
This report presents a comprehensive overview, market shares, and growth opportunities of KRAS G12C Inhibitors market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Garsorasib
- Fulzerasib
- Adagrasib
- Sotorasib
- Hospital
- Clinic
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Amgen
- Innovent Biologics, Inc.
- Mirati Therapeutics
- Genfleet Therapeutics (Shanghai), Inc.
What is the 10-year outlook for the global KRAS G12C Inhibitors market?
What factors are driving KRAS G12C Inhibitors market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do KRAS G12C Inhibitors market opportunities vary by end market size?
How does KRAS G12C Inhibitors break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global KRAS G12C Inhibitors Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for KRAS G12C Inhibitors by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for KRAS G12C Inhibitors by Country/Region, 2021, 2025 & 2032
2.2 KRAS G12C Inhibitors Segment by Type
2.2.1 Garsorasib
2.2.2 Fulzerasib
2.2.3 Adagrasib
2.2.4 Sotorasib
2.2.5 KRAS G12C Inhibitors Sales by Type
2.2.5.1 Global KRAS G12C Inhibitors Sales Market Share by Type (2021-2026)
2.2.5.2 Global KRAS G12C Inhibitors Revenue and Market Share by Type (2021-2026)
2.2.5.3 Global KRAS G12C Inhibitors Sale Price by Type (2021-2026)
2.3 KRAS G12C Inhibitors Segment by Application
2.3.1 Hospital
2.3.2 Clinic
2.3.3 Others
2.3.4 KRAS G12C Inhibitors Sales by Application
2.3.4.1 Global KRAS G12C Inhibitors Sale Market Share by Application (2021-2026)
2.3.4.2 Global KRAS G12C Inhibitors Revenue and Market Share by Application (2021-2026)
2.3.4.3 Global KRAS G12C Inhibitors Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global KRAS G12C Inhibitors Breakdown Data by Company
3.1.1 Global KRAS G12C Inhibitors Annual Sales by Company (2021-2026)
3.1.2 Global KRAS G12C Inhibitors Sales Market Share by Company (2021-2026)
3.2 Global KRAS G12C Inhibitors Annual Revenue by Company (2021-2026)
3.2.1 Global KRAS G12C Inhibitors Revenue by Company (2021-2026)
3.2.2 Global KRAS G12C Inhibitors Revenue Market Share by Company (2021-2026)
3.3 Global KRAS G12C Inhibitors Sale Price by Company
3.4 Key Manufacturers KRAS G12C Inhibitors Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers KRAS G12C Inhibitors Product Location Distribution
3.4.2 Players KRAS G12C Inhibitors Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR KRAS G12C INHIBITORS BY GEOGRAPHIC REGION
4.1 World Historic KRAS G12C Inhibitors Market Size by Geographic Region (2021-2026)
4.1.1 Global KRAS G12C Inhibitors Annual Sales by Geographic Region (2021-2026)
4.1.2 Global KRAS G12C Inhibitors Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic KRAS G12C Inhibitors Market Size by Country/Region (2021-2026)
4.2.1 Global KRAS G12C Inhibitors Annual Sales by Country/Region (2021-2026)
4.2.2 Global KRAS G12C Inhibitors Annual Revenue by Country/Region (2021-2026)
4.3 Americas KRAS G12C Inhibitors Sales Growth
4.4 APAC KRAS G12C Inhibitors Sales Growth
4.5 Europe KRAS G12C Inhibitors Sales Growth
4.6 Middle East & Africa KRAS G12C Inhibitors Sales Growth
5 AMERICAS
5.1 Americas KRAS G12C Inhibitors Sales by Country
5.1.1 Americas KRAS G12C Inhibitors Sales by Country (2021-2026)
5.1.2 Americas KRAS G12C Inhibitors Revenue by Country (2021-2026)
5.2 Americas KRAS G12C Inhibitors Sales by Type (2021-2026)
5.3 Americas KRAS G12C Inhibitors Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC KRAS G12C Inhibitors Sales by Region
6.1.1 APAC KRAS G12C Inhibitors Sales by Region (2021-2026)
6.1.2 APAC KRAS G12C Inhibitors Revenue by Region (2021-2026)
6.2 APAC KRAS G12C Inhibitors Sales by Type (2021-2026)
6.3 APAC KRAS G12C Inhibitors Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe KRAS G12C Inhibitors by Country
7.1.1 Europe KRAS G12C Inhibitors Sales by Country (2021-2026)
7.1.2 Europe KRAS G12C Inhibitors Revenue by Country (2021-2026)
7.2 Europe KRAS G12C Inhibitors Sales by Type (2021-2026)
7.3 Europe KRAS G12C Inhibitors Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa KRAS G12C Inhibitors by Country
8.1.1 Middle East & Africa KRAS G12C Inhibitors Sales by Country (2021-2026)
8.1.2 Middle East & Africa KRAS G12C Inhibitors Revenue by Country (2021-2026)
8.2 Middle East & Africa KRAS G12C Inhibitors Sales by Type (2021-2026)
8.3 Middle East & Africa KRAS G12C Inhibitors Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of KRAS G12C Inhibitors
10.3 Manufacturing Process Analysis of KRAS G12C Inhibitors
10.4 Industry Chain Structure of KRAS G12C Inhibitors
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 KRAS G12C Inhibitors Distributors
11.3 KRAS G12C Inhibitors Customer
12 WORLD FORECAST REVIEW FOR KRAS G12C INHIBITORS BY GEOGRAPHIC REGION
12.1 Global KRAS G12C Inhibitors Market Size Forecast by Region
12.1.1 Global KRAS G12C Inhibitors Forecast by Region (2027-2032)
12.1.2 Global KRAS G12C Inhibitors Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global KRAS G12C Inhibitors Forecast by Type (2027-2032)
12.7 Global KRAS G12C Inhibitors Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Amgen
13.1.1 Amgen Company Information
13.1.2 Amgen KRAS G12C Inhibitors Product Portfolios and Specifications
13.1.3 Amgen KRAS G12C Inhibitors Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Amgen Main Business Overview
13.1.5 Amgen Latest Developments
13.2 Innovent Biologics, Inc.
13.2.1 Innovent Biologics, Inc. Company Information
13.2.2 Innovent Biologics, Inc. KRAS G12C Inhibitors Product Portfolios and Specifications
13.2.3 Innovent Biologics, Inc. KRAS G12C Inhibitors Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Innovent Biologics, Inc. Main Business Overview
13.2.5 Innovent Biologics, Inc. Latest Developments
13.3 Mirati Therapeutics
13.3.1 Mirati Therapeutics Company Information
13.3.2 Mirati Therapeutics KRAS G12C Inhibitors Product Portfolios and Specifications
13.3.3 Mirati Therapeutics KRAS G12C Inhibitors Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Mirati Therapeutics Main Business Overview
13.3.5 Mirati Therapeutics Latest Developments
13.4 Genfleet Therapeutics (Shanghai), Inc.
13.4.1 Genfleet Therapeutics (Shanghai), Inc. Company Information
13.4.2 Genfleet Therapeutics (Shanghai), Inc. KRAS G12C Inhibitors Product Portfolios and Specifications
13.4.3 Genfleet Therapeutics (Shanghai), Inc. KRAS G12C Inhibitors Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Genfleet Therapeutics (Shanghai), Inc. Main Business Overview
13.4.5 Genfleet Therapeutics (Shanghai), Inc. Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global KRAS G12C Inhibitors Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for KRAS G12C Inhibitors by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for KRAS G12C Inhibitors by Country/Region, 2021, 2025 & 2032
2.2 KRAS G12C Inhibitors Segment by Type
2.2.1 Garsorasib
2.2.2 Fulzerasib
2.2.3 Adagrasib
2.2.4 Sotorasib
2.2.5 KRAS G12C Inhibitors Sales by Type
2.2.5.1 Global KRAS G12C Inhibitors Sales Market Share by Type (2021-2026)
2.2.5.2 Global KRAS G12C Inhibitors Revenue and Market Share by Type (2021-2026)
2.2.5.3 Global KRAS G12C Inhibitors Sale Price by Type (2021-2026)
2.3 KRAS G12C Inhibitors Segment by Application
2.3.1 Hospital
2.3.2 Clinic
2.3.3 Others
2.3.4 KRAS G12C Inhibitors Sales by Application
2.3.4.1 Global KRAS G12C Inhibitors Sale Market Share by Application (2021-2026)
2.3.4.2 Global KRAS G12C Inhibitors Revenue and Market Share by Application (2021-2026)
2.3.4.3 Global KRAS G12C Inhibitors Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global KRAS G12C Inhibitors Breakdown Data by Company
3.1.1 Global KRAS G12C Inhibitors Annual Sales by Company (2021-2026)
3.1.2 Global KRAS G12C Inhibitors Sales Market Share by Company (2021-2026)
3.2 Global KRAS G12C Inhibitors Annual Revenue by Company (2021-2026)
3.2.1 Global KRAS G12C Inhibitors Revenue by Company (2021-2026)
3.2.2 Global KRAS G12C Inhibitors Revenue Market Share by Company (2021-2026)
3.3 Global KRAS G12C Inhibitors Sale Price by Company
3.4 Key Manufacturers KRAS G12C Inhibitors Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers KRAS G12C Inhibitors Product Location Distribution
3.4.2 Players KRAS G12C Inhibitors Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR KRAS G12C INHIBITORS BY GEOGRAPHIC REGION
4.1 World Historic KRAS G12C Inhibitors Market Size by Geographic Region (2021-2026)
4.1.1 Global KRAS G12C Inhibitors Annual Sales by Geographic Region (2021-2026)
4.1.2 Global KRAS G12C Inhibitors Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic KRAS G12C Inhibitors Market Size by Country/Region (2021-2026)
4.2.1 Global KRAS G12C Inhibitors Annual Sales by Country/Region (2021-2026)
4.2.2 Global KRAS G12C Inhibitors Annual Revenue by Country/Region (2021-2026)
4.3 Americas KRAS G12C Inhibitors Sales Growth
4.4 APAC KRAS G12C Inhibitors Sales Growth
4.5 Europe KRAS G12C Inhibitors Sales Growth
4.6 Middle East & Africa KRAS G12C Inhibitors Sales Growth
5 AMERICAS
5.1 Americas KRAS G12C Inhibitors Sales by Country
5.1.1 Americas KRAS G12C Inhibitors Sales by Country (2021-2026)
5.1.2 Americas KRAS G12C Inhibitors Revenue by Country (2021-2026)
5.2 Americas KRAS G12C Inhibitors Sales by Type (2021-2026)
5.3 Americas KRAS G12C Inhibitors Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC KRAS G12C Inhibitors Sales by Region
6.1.1 APAC KRAS G12C Inhibitors Sales by Region (2021-2026)
6.1.2 APAC KRAS G12C Inhibitors Revenue by Region (2021-2026)
6.2 APAC KRAS G12C Inhibitors Sales by Type (2021-2026)
6.3 APAC KRAS G12C Inhibitors Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe KRAS G12C Inhibitors by Country
7.1.1 Europe KRAS G12C Inhibitors Sales by Country (2021-2026)
7.1.2 Europe KRAS G12C Inhibitors Revenue by Country (2021-2026)
7.2 Europe KRAS G12C Inhibitors Sales by Type (2021-2026)
7.3 Europe KRAS G12C Inhibitors Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa KRAS G12C Inhibitors by Country
8.1.1 Middle East & Africa KRAS G12C Inhibitors Sales by Country (2021-2026)
8.1.2 Middle East & Africa KRAS G12C Inhibitors Revenue by Country (2021-2026)
8.2 Middle East & Africa KRAS G12C Inhibitors Sales by Type (2021-2026)
8.3 Middle East & Africa KRAS G12C Inhibitors Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of KRAS G12C Inhibitors
10.3 Manufacturing Process Analysis of KRAS G12C Inhibitors
10.4 Industry Chain Structure of KRAS G12C Inhibitors
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 KRAS G12C Inhibitors Distributors
11.3 KRAS G12C Inhibitors Customer
12 WORLD FORECAST REVIEW FOR KRAS G12C INHIBITORS BY GEOGRAPHIC REGION
12.1 Global KRAS G12C Inhibitors Market Size Forecast by Region
12.1.1 Global KRAS G12C Inhibitors Forecast by Region (2027-2032)
12.1.2 Global KRAS G12C Inhibitors Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global KRAS G12C Inhibitors Forecast by Type (2027-2032)
12.7 Global KRAS G12C Inhibitors Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Amgen
13.1.1 Amgen Company Information
13.1.2 Amgen KRAS G12C Inhibitors Product Portfolios and Specifications
13.1.3 Amgen KRAS G12C Inhibitors Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Amgen Main Business Overview
13.1.5 Amgen Latest Developments
13.2 Innovent Biologics, Inc.
13.2.1 Innovent Biologics, Inc. Company Information
13.2.2 Innovent Biologics, Inc. KRAS G12C Inhibitors Product Portfolios and Specifications
13.2.3 Innovent Biologics, Inc. KRAS G12C Inhibitors Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Innovent Biologics, Inc. Main Business Overview
13.2.5 Innovent Biologics, Inc. Latest Developments
13.3 Mirati Therapeutics
13.3.1 Mirati Therapeutics Company Information
13.3.2 Mirati Therapeutics KRAS G12C Inhibitors Product Portfolios and Specifications
13.3.3 Mirati Therapeutics KRAS G12C Inhibitors Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Mirati Therapeutics Main Business Overview
13.3.5 Mirati Therapeutics Latest Developments
13.4 Genfleet Therapeutics (Shanghai), Inc.
13.4.1 Genfleet Therapeutics (Shanghai), Inc. Company Information
13.4.2 Genfleet Therapeutics (Shanghai), Inc. KRAS G12C Inhibitors Product Portfolios and Specifications
13.4.3 Genfleet Therapeutics (Shanghai), Inc. KRAS G12C Inhibitors Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Genfleet Therapeutics (Shanghai), Inc. Main Business Overview
13.4.5 Genfleet Therapeutics (Shanghai), Inc. Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. KRAS G12C Inhibitors Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. KRAS G12C Inhibitors Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Garsorasib
Table 4. Major Players of Fulzerasib
Table 5. Major Players of Adagrasib
Table 6. Major Players of Sotorasib
Table 7. Global KRAS G12C Inhibitors Sales by Type (2021-2026) & (K Units)
Table 8. Global KRAS G12C Inhibitors Sales Market Share by Type (2021-2026)
Table 9. Global KRAS G12C Inhibitors Revenue by Type (2021-2026) & ($ million)
Table 10. Global KRAS G12C Inhibitors Revenue Market Share by Type (2021-2026)
Table 11. Global KRAS G12C Inhibitors Sale Price by Type (2021-2026) & (US$/Unit)
Table 12. Global KRAS G12C Inhibitors Sale by Application (2021-2026) & (K Units)
Table 13. Global KRAS G12C Inhibitors Sale Market Share by Application (2021-2026)
Table 14. Global KRAS G12C Inhibitors Revenue by Application (2021-2026) & ($ million)
Table 15. Global KRAS G12C Inhibitors Revenue Market Share by Application (2021-2026)
Table 16. Global KRAS G12C Inhibitors Sale Price by Application (2021-2026) & (US$/Unit)
Table 17. Global KRAS G12C Inhibitors Sales by Company (2021-2026) & (K Units)
Table 18. Global KRAS G12C Inhibitors Sales Market Share by Company (2021-2026)
Table 19. Global KRAS G12C Inhibitors Revenue by Company (2021-2026) & ($ millions)
Table 20. Global KRAS G12C Inhibitors Revenue Market Share by Company (2021-2026)
Table 21. Global KRAS G12C Inhibitors Sale Price by Company (2021-2026) & (US$/Unit)
Table 22. Key Manufacturers KRAS G12C Inhibitors Producing Area Distribution and Sales Area
Table 23. Players KRAS G12C Inhibitors Products Offered
Table 24. KRAS G12C Inhibitors Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 25. New Products and Potential Entrants
Table 26. Market M&A Activity & Strategy
Table 27. Global KRAS G12C Inhibitors Sales by Geographic Region (2021-2026) & (K Units)
Table 28. Global KRAS G12C Inhibitors Sales Market Share Geographic Region (2021-2026)
Table 29. Global KRAS G12C Inhibitors Revenue by Geographic Region (2021-2026) & ($ millions)
Table 30. Global KRAS G12C Inhibitors Revenue Market Share by Geographic Region (2021-2026)
Table 31. Global KRAS G12C Inhibitors Sales by Country/Region (2021-2026) & (K Units)
Table 32. Global KRAS G12C Inhibitors Sales Market Share by Country/Region (2021-2026)
Table 33. Global KRAS G12C Inhibitors Revenue by Country/Region (2021-2026) & ($ millions)
Table 34. Global KRAS G12C Inhibitors Revenue Market Share by Country/Region (2021-2026)
Table 35. Americas KRAS G12C Inhibitors Sales by Country (2021-2026) & (K Units)
Table 36. Americas KRAS G12C Inhibitors Sales Market Share by Country (2021-2026)
Table 37. Americas KRAS G12C Inhibitors Revenue by Country (2021-2026) & ($ millions)
Table 38. Americas KRAS G12C Inhibitors Sales by Type (2021-2026) & (K Units)
Table 39. Americas KRAS G12C Inhibitors Sales by Application (2021-2026) & (K Units)
Table 40. APAC KRAS G12C Inhibitors Sales by Region (2021-2026) & (K Units)
Table 41. APAC KRAS G12C Inhibitors Sales Market Share by Region (2021-2026)
Table 42. APAC KRAS G12C Inhibitors Revenue by Region (2021-2026) & ($ millions)
Table 43. APAC KRAS G12C Inhibitors Sales by Type (2021-2026) & (K Units)
Table 44. APAC KRAS G12C Inhibitors Sales by Application (2021-2026) & (K Units)
Table 45. Europe KRAS G12C Inhibitors Sales by Country (2021-2026) & (K Units)
Table 46. Europe KRAS G12C Inhibitors Revenue by Country (2021-2026) & ($ millions)
Table 47. Europe KRAS G12C Inhibitors Sales by Type (2021-2026) & (K Units)
Table 48. Europe KRAS G12C Inhibitors Sales by Application (2021-2026) & (K Units)
Table 49. Middle East & Africa KRAS G12C Inhibitors Sales by Country (2021-2026) & (K Units)
Table 50. Middle East & Africa KRAS G12C Inhibitors Revenue Market Share by Country (2021-2026)
Table 51. Middle East & Africa KRAS G12C Inhibitors Sales by Type (2021-2026) & (K Units)
Table 52. Middle East & Africa KRAS G12C Inhibitors Sales by Application (2021-2026) & (K Units)
Table 53. Key Market Drivers & Growth Opportunities of KRAS G12C Inhibitors
Table 54. Key Market Challenges & Risks of KRAS G12C Inhibitors
Table 55. Key Industry Trends of KRAS G12C Inhibitors
Table 56. KRAS G12C Inhibitors Raw Material
Table 57. Key Suppliers of Raw Materials
Table 58. KRAS G12C Inhibitors Distributors List
Table 59. KRAS G12C Inhibitors Customer List
Table 60. Global KRAS G12C Inhibitors Sales Forecast by Region (2027-2032) & (K Units)
Table 61. Global KRAS G12C Inhibitors Revenue Forecast by Region (2027-2032) & ($ millions)
Table 62. Americas KRAS G12C Inhibitors Sales Forecast by Country (2027-2032) & (K Units)
Table 63. Americas KRAS G12C Inhibitors Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 64. APAC KRAS G12C Inhibitors Sales Forecast by Region (2027-2032) & (K Units)
Table 65. APAC KRAS G12C Inhibitors Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 66. Europe KRAS G12C Inhibitors Sales Forecast by Country (2027-2032) & (K Units)
Table 67. Europe KRAS G12C Inhibitors Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Middle East & Africa KRAS G12C Inhibitors Sales Forecast by Country (2027-2032) & (K Units)
Table 69. Middle East & Africa KRAS G12C Inhibitors Revenue Forecast by Country (2027-2032) & ($ millions)
Table 70. Global KRAS G12C Inhibitors Sales Forecast by Type (2027-2032) & (K Units)
Table 71. Global KRAS G12C Inhibitors Revenue Forecast by Type (2027-2032) & ($ millions)
Table 72. Global KRAS G12C Inhibitors Sales Forecast by Application (2027-2032) & (K Units)
Table 73. Global KRAS G12C Inhibitors Revenue Forecast by Application (2027-2032) & ($ millions)
Table 74. Amgen Basic Information, KRAS G12C Inhibitors Manufacturing Base, Sales Area and Its Competitors
Table 75. Amgen KRAS G12C Inhibitors Product Portfolios and Specifications
Table 76. Amgen KRAS G12C Inhibitors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 77. Amgen Main Business
Table 78. Amgen Latest Developments
Table 79. Innovent Biologics, Inc. Basic Information, KRAS G12C Inhibitors Manufacturing Base, Sales Area and Its Competitors
Table 80. Innovent Biologics, Inc. KRAS G12C Inhibitors Product Portfolios and Specifications
Table 81. Innovent Biologics, Inc. KRAS G12C Inhibitors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 82. Innovent Biologics, Inc. Main Business
Table 83. Innovent Biologics, Inc. Latest Developments
Table 84. Mirati Therapeutics Basic Information, KRAS G12C Inhibitors Manufacturing Base, Sales Area and Its Competitors
Table 85. Mirati Therapeutics KRAS G12C Inhibitors Product Portfolios and Specifications
Table 86. Mirati Therapeutics KRAS G12C Inhibitors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 87. Mirati Therapeutics Main Business
Table 88. Mirati Therapeutics Latest Developments
Table 89. Genfleet Therapeutics (Shanghai), Inc. Basic Information, KRAS G12C Inhibitors Manufacturing Base, Sales Area and Its Competitors
Table 90. Genfleet Therapeutics (Shanghai), Inc. KRAS G12C Inhibitors Product Portfolios and Specifications
Table 91. Genfleet Therapeutics (Shanghai), Inc. KRAS G12C Inhibitors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 92. Genfleet Therapeutics (Shanghai), Inc. Main Business
Table 93. Genfleet Therapeutics (Shanghai), Inc. Latest Developments
Table 1. KRAS G12C Inhibitors Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. KRAS G12C Inhibitors Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Garsorasib
Table 4. Major Players of Fulzerasib
Table 5. Major Players of Adagrasib
Table 6. Major Players of Sotorasib
Table 7. Global KRAS G12C Inhibitors Sales by Type (2021-2026) & (K Units)
Table 8. Global KRAS G12C Inhibitors Sales Market Share by Type (2021-2026)
Table 9. Global KRAS G12C Inhibitors Revenue by Type (2021-2026) & ($ million)
Table 10. Global KRAS G12C Inhibitors Revenue Market Share by Type (2021-2026)
Table 11. Global KRAS G12C Inhibitors Sale Price by Type (2021-2026) & (US$/Unit)
Table 12. Global KRAS G12C Inhibitors Sale by Application (2021-2026) & (K Units)
Table 13. Global KRAS G12C Inhibitors Sale Market Share by Application (2021-2026)
Table 14. Global KRAS G12C Inhibitors Revenue by Application (2021-2026) & ($ million)
Table 15. Global KRAS G12C Inhibitors Revenue Market Share by Application (2021-2026)
Table 16. Global KRAS G12C Inhibitors Sale Price by Application (2021-2026) & (US$/Unit)
Table 17. Global KRAS G12C Inhibitors Sales by Company (2021-2026) & (K Units)
Table 18. Global KRAS G12C Inhibitors Sales Market Share by Company (2021-2026)
Table 19. Global KRAS G12C Inhibitors Revenue by Company (2021-2026) & ($ millions)
Table 20. Global KRAS G12C Inhibitors Revenue Market Share by Company (2021-2026)
Table 21. Global KRAS G12C Inhibitors Sale Price by Company (2021-2026) & (US$/Unit)
Table 22. Key Manufacturers KRAS G12C Inhibitors Producing Area Distribution and Sales Area
Table 23. Players KRAS G12C Inhibitors Products Offered
Table 24. KRAS G12C Inhibitors Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 25. New Products and Potential Entrants
Table 26. Market M&A Activity & Strategy
Table 27. Global KRAS G12C Inhibitors Sales by Geographic Region (2021-2026) & (K Units)
Table 28. Global KRAS G12C Inhibitors Sales Market Share Geographic Region (2021-2026)
Table 29. Global KRAS G12C Inhibitors Revenue by Geographic Region (2021-2026) & ($ millions)
Table 30. Global KRAS G12C Inhibitors Revenue Market Share by Geographic Region (2021-2026)
Table 31. Global KRAS G12C Inhibitors Sales by Country/Region (2021-2026) & (K Units)
Table 32. Global KRAS G12C Inhibitors Sales Market Share by Country/Region (2021-2026)
Table 33. Global KRAS G12C Inhibitors Revenue by Country/Region (2021-2026) & ($ millions)
Table 34. Global KRAS G12C Inhibitors Revenue Market Share by Country/Region (2021-2026)
Table 35. Americas KRAS G12C Inhibitors Sales by Country (2021-2026) & (K Units)
Table 36. Americas KRAS G12C Inhibitors Sales Market Share by Country (2021-2026)
Table 37. Americas KRAS G12C Inhibitors Revenue by Country (2021-2026) & ($ millions)
Table 38. Americas KRAS G12C Inhibitors Sales by Type (2021-2026) & (K Units)
Table 39. Americas KRAS G12C Inhibitors Sales by Application (2021-2026) & (K Units)
Table 40. APAC KRAS G12C Inhibitors Sales by Region (2021-2026) & (K Units)
Table 41. APAC KRAS G12C Inhibitors Sales Market Share by Region (2021-2026)
Table 42. APAC KRAS G12C Inhibitors Revenue by Region (2021-2026) & ($ millions)
Table 43. APAC KRAS G12C Inhibitors Sales by Type (2021-2026) & (K Units)
Table 44. APAC KRAS G12C Inhibitors Sales by Application (2021-2026) & (K Units)
Table 45. Europe KRAS G12C Inhibitors Sales by Country (2021-2026) & (K Units)
Table 46. Europe KRAS G12C Inhibitors Revenue by Country (2021-2026) & ($ millions)
Table 47. Europe KRAS G12C Inhibitors Sales by Type (2021-2026) & (K Units)
Table 48. Europe KRAS G12C Inhibitors Sales by Application (2021-2026) & (K Units)
Table 49. Middle East & Africa KRAS G12C Inhibitors Sales by Country (2021-2026) & (K Units)
Table 50. Middle East & Africa KRAS G12C Inhibitors Revenue Market Share by Country (2021-2026)
Table 51. Middle East & Africa KRAS G12C Inhibitors Sales by Type (2021-2026) & (K Units)
Table 52. Middle East & Africa KRAS G12C Inhibitors Sales by Application (2021-2026) & (K Units)
Table 53. Key Market Drivers & Growth Opportunities of KRAS G12C Inhibitors
Table 54. Key Market Challenges & Risks of KRAS G12C Inhibitors
Table 55. Key Industry Trends of KRAS G12C Inhibitors
Table 56. KRAS G12C Inhibitors Raw Material
Table 57. Key Suppliers of Raw Materials
Table 58. KRAS G12C Inhibitors Distributors List
Table 59. KRAS G12C Inhibitors Customer List
Table 60. Global KRAS G12C Inhibitors Sales Forecast by Region (2027-2032) & (K Units)
Table 61. Global KRAS G12C Inhibitors Revenue Forecast by Region (2027-2032) & ($ millions)
Table 62. Americas KRAS G12C Inhibitors Sales Forecast by Country (2027-2032) & (K Units)
Table 63. Americas KRAS G12C Inhibitors Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 64. APAC KRAS G12C Inhibitors Sales Forecast by Region (2027-2032) & (K Units)
Table 65. APAC KRAS G12C Inhibitors Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 66. Europe KRAS G12C Inhibitors Sales Forecast by Country (2027-2032) & (K Units)
Table 67. Europe KRAS G12C Inhibitors Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Middle East & Africa KRAS G12C Inhibitors Sales Forecast by Country (2027-2032) & (K Units)
Table 69. Middle East & Africa KRAS G12C Inhibitors Revenue Forecast by Country (2027-2032) & ($ millions)
Table 70. Global KRAS G12C Inhibitors Sales Forecast by Type (2027-2032) & (K Units)
Table 71. Global KRAS G12C Inhibitors Revenue Forecast by Type (2027-2032) & ($ millions)
Table 72. Global KRAS G12C Inhibitors Sales Forecast by Application (2027-2032) & (K Units)
Table 73. Global KRAS G12C Inhibitors Revenue Forecast by Application (2027-2032) & ($ millions)
Table 74. Amgen Basic Information, KRAS G12C Inhibitors Manufacturing Base, Sales Area and Its Competitors
Table 75. Amgen KRAS G12C Inhibitors Product Portfolios and Specifications
Table 76. Amgen KRAS G12C Inhibitors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 77. Amgen Main Business
Table 78. Amgen Latest Developments
Table 79. Innovent Biologics, Inc. Basic Information, KRAS G12C Inhibitors Manufacturing Base, Sales Area and Its Competitors
Table 80. Innovent Biologics, Inc. KRAS G12C Inhibitors Product Portfolios and Specifications
Table 81. Innovent Biologics, Inc. KRAS G12C Inhibitors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 82. Innovent Biologics, Inc. Main Business
Table 83. Innovent Biologics, Inc. Latest Developments
Table 84. Mirati Therapeutics Basic Information, KRAS G12C Inhibitors Manufacturing Base, Sales Area and Its Competitors
Table 85. Mirati Therapeutics KRAS G12C Inhibitors Product Portfolios and Specifications
Table 86. Mirati Therapeutics KRAS G12C Inhibitors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 87. Mirati Therapeutics Main Business
Table 88. Mirati Therapeutics Latest Developments
Table 89. Genfleet Therapeutics (Shanghai), Inc. Basic Information, KRAS G12C Inhibitors Manufacturing Base, Sales Area and Its Competitors
Table 90. Genfleet Therapeutics (Shanghai), Inc. KRAS G12C Inhibitors Product Portfolios and Specifications
Table 91. Genfleet Therapeutics (Shanghai), Inc. KRAS G12C Inhibitors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 92. Genfleet Therapeutics (Shanghai), Inc. Main Business
Table 93. Genfleet Therapeutics (Shanghai), Inc. Latest Developments
LIST OF FIGURES
Figure 1. Picture of KRAS G12C Inhibitors
Figure 2. KRAS G12C Inhibitors Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global KRAS G12C Inhibitors Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global KRAS G12C Inhibitors Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. KRAS G12C Inhibitors Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. KRAS G12C Inhibitors Sales Market Share by Country/Region (2025)
Figure 10. KRAS G12C Inhibitors Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Garsorasib
Figure 12. Product Picture of Fulzerasib
Figure 13. Product Picture of Adagrasib
Figure 14. Product Picture of Sotorasib
Figure 15. Global KRAS G12C Inhibitors Sales Market Share by Type in 2026
Figure 16. Global KRAS G12C Inhibitors Revenue Market Share by Type (2021-2026)
Figure 17. KRAS G12C Inhibitors Consumed in Hospital
Figure 18. Global KRAS G12C Inhibitors Market: Hospital (2021-2026) & (K Units)
Figure 19. KRAS G12C Inhibitors Consumed in Clinic
Figure 20. Global KRAS G12C Inhibitors Market: Clinic (2021-2026) & (K Units)
Figure 21. KRAS G12C Inhibitors Consumed in Others
Figure 22. Global KRAS G12C Inhibitors Market: Others (2021-2026) & (K Units)
Figure 23. Global KRAS G12C Inhibitors Sale Market Share by Application (2025)
Figure 24. Global KRAS G12C Inhibitors Revenue Market Share by Application in 2026
Figure 25. KRAS G12C Inhibitors Sales by Company in 2026 (K Units)
Figure 26. Global KRAS G12C Inhibitors Sales Market Share by Company in 2026
Figure 27. KRAS G12C Inhibitors Revenue by Company in 2026 ($ millions)
Figure 28. Global KRAS G12C Inhibitors Revenue Market Share by Company in 2026
Figure 29. Global KRAS G12C Inhibitors Sales Market Share by Geographic Region (2021-2026)
Figure 30. Global KRAS G12C Inhibitors Revenue Market Share by Geographic Region in 2026
Figure 31. Americas KRAS G12C Inhibitors Sales 2021-2026 (K Units)
Figure 32. Americas KRAS G12C Inhibitors Revenue 2021-2026 ($ millions)
Figure 33. APAC KRAS G12C Inhibitors Sales 2021-2026 (K Units)
Figure 34. APAC KRAS G12C Inhibitors Revenue 2021-2026 ($ millions)
Figure 35. Europe KRAS G12C Inhibitors Sales 2021-2026 (K Units)
Figure 36. Europe KRAS G12C Inhibitors Revenue 2021-2026 ($ millions)
Figure 37. Middle East & Africa KRAS G12C Inhibitors Sales 2021-2026 (K Units)
Figure 38. Middle East & Africa KRAS G12C Inhibitors Revenue 2021-2026 ($ millions)
Figure 39. Americas KRAS G12C Inhibitors Sales Market Share by Country in 2026
Figure 40. Americas KRAS G12C Inhibitors Revenue Market Share by Country (2021-2026)
Figure 41. Americas KRAS G12C Inhibitors Sales Market Share by Type (2021-2026)
Figure 42. Americas KRAS G12C Inhibitors Sales Market Share by Application (2021-2026)
Figure 43. United States KRAS G12C Inhibitors Revenue Growth 2021-2026 ($ millions)
Figure 44. Canada KRAS G12C Inhibitors Revenue Growth 2021-2026 ($ millions)
Figure 45. Mexico KRAS G12C Inhibitors Revenue Growth 2021-2026 ($ millions)
Figure 46. Brazil KRAS G12C Inhibitors Revenue Growth 2021-2026 ($ millions)
Figure 47. APAC KRAS G12C Inhibitors Sales Market Share by Region in 2026
Figure 48. APAC KRAS G12C Inhibitors Revenue Market Share by Region (2021-2026)
Figure 49. APAC KRAS G12C Inhibitors Sales Market Share by Type (2021-2026)
Figure 50. APAC KRAS G12C Inhibitors Sales Market Share by Application (2021-2026)
Figure 51. China KRAS G12C Inhibitors Revenue Growth 2021-2026 ($ millions)
Figure 52. Japan KRAS G12C Inhibitors Revenue Growth 2021-2026 ($ millions)
Figure 53. South Korea KRAS G12C Inhibitors Revenue Growth 2021-2026 ($ millions)
Figure 54. Southeast Asia KRAS G12C Inhibitors Revenue Growth 2021-2026 ($ millions)
Figure 55. India KRAS G12C Inhibitors Revenue Growth 2021-2026 ($ millions)
Figure 56. Australia KRAS G12C Inhibitors Revenue Growth 2021-2026 ($ millions)
Figure 57. China Taiwan KRAS G12C Inhibitors Revenue Growth 2021-2026 ($ millions)
Figure 58. Europe KRAS G12C Inhibitors Sales Market Share by Country in 2026
Figure 59. Europe KRAS G12C Inhibitors Revenue Market Share by Country (2021-2026)
Figure 60. Europe KRAS G12C Inhibitors Sales Market Share by Type (2021-2026)
Figure 61. Europe KRAS G12C Inhibitors Sales Market Share by Application (2021-2026)
Figure 62. Germany KRAS G12C Inhibitors Revenue Growth 2021-2026 ($ millions)
Figure 63. France KRAS G12C Inhibitors Revenue Growth 2021-2026 ($ millions)
Figure 64. UK KRAS G12C Inhibitors Revenue Growth 2021-2026 ($ millions)
Figure 65. Italy KRAS G12C Inhibitors Revenue Growth 2021-2026 ($ millions)
Figure 66. Russia KRAS G12C Inhibitors Revenue Growth 2021-2026 ($ millions)
Figure 67. Middle East & Africa KRAS G12C Inhibitors Sales Market Share by Country (2021-2026)
Figure 68. Middle East & Africa KRAS G12C Inhibitors Sales Market Share by Type (2021-2026)
Figure 69. Middle East & Africa KRAS G12C Inhibitors Sales Market Share by Application (2021-2026)
Figure 70. Egypt KRAS G12C Inhibitors Revenue Growth 2021-2026 ($ millions)
Figure 71. South Africa KRAS G12C Inhibitors Revenue Growth 2021-2026 ($ millions)
Figure 72. Israel KRAS G12C Inhibitors Revenue Growth 2021-2026 ($ millions)
Figure 73. Turkey KRAS G12C Inhibitors Revenue Growth 2021-2026 ($ millions)
Figure 74. GCC Countries KRAS G12C Inhibitors Revenue Growth 2021-2026 ($ millions)
Figure 75. Manufacturing Cost Structure Analysis of KRAS G12C Inhibitors in 2026
Figure 76. Manufacturing Process Analysis of KRAS G12C Inhibitors
Figure 77. Industry Chain Structure of KRAS G12C Inhibitors
Figure 78. Channels of Distribution
Figure 79. Global KRAS G12C Inhibitors Sales Market Forecast by Region (2027-2032)
Figure 80. Global KRAS G12C Inhibitors Revenue Market Share Forecast by Region (2027-2032)
Figure 81. Global KRAS G12C Inhibitors Sales Market Share Forecast by Type (2027-2032)
Figure 82. Global KRAS G12C Inhibitors Revenue Market Share Forecast by Type (2027-2032)
Figure 83. Global KRAS G12C Inhibitors Sales Market Share Forecast by Application (2027-2032)
Figure 84. Global KRAS G12C Inhibitors Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of KRAS G12C Inhibitors
Figure 2. KRAS G12C Inhibitors Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global KRAS G12C Inhibitors Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global KRAS G12C Inhibitors Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. KRAS G12C Inhibitors Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. KRAS G12C Inhibitors Sales Market Share by Country/Region (2025)
Figure 10. KRAS G12C Inhibitors Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Garsorasib
Figure 12. Product Picture of Fulzerasib
Figure 13. Product Picture of Adagrasib
Figure 14. Product Picture of Sotorasib
Figure 15. Global KRAS G12C Inhibitors Sales Market Share by Type in 2026
Figure 16. Global KRAS G12C Inhibitors Revenue Market Share by Type (2021-2026)
Figure 17. KRAS G12C Inhibitors Consumed in Hospital
Figure 18. Global KRAS G12C Inhibitors Market: Hospital (2021-2026) & (K Units)
Figure 19. KRAS G12C Inhibitors Consumed in Clinic
Figure 20. Global KRAS G12C Inhibitors Market: Clinic (2021-2026) & (K Units)
Figure 21. KRAS G12C Inhibitors Consumed in Others
Figure 22. Global KRAS G12C Inhibitors Market: Others (2021-2026) & (K Units)
Figure 23. Global KRAS G12C Inhibitors Sale Market Share by Application (2025)
Figure 24. Global KRAS G12C Inhibitors Revenue Market Share by Application in 2026
Figure 25. KRAS G12C Inhibitors Sales by Company in 2026 (K Units)
Figure 26. Global KRAS G12C Inhibitors Sales Market Share by Company in 2026
Figure 27. KRAS G12C Inhibitors Revenue by Company in 2026 ($ millions)
Figure 28. Global KRAS G12C Inhibitors Revenue Market Share by Company in 2026
Figure 29. Global KRAS G12C Inhibitors Sales Market Share by Geographic Region (2021-2026)
Figure 30. Global KRAS G12C Inhibitors Revenue Market Share by Geographic Region in 2026
Figure 31. Americas KRAS G12C Inhibitors Sales 2021-2026 (K Units)
Figure 32. Americas KRAS G12C Inhibitors Revenue 2021-2026 ($ millions)
Figure 33. APAC KRAS G12C Inhibitors Sales 2021-2026 (K Units)
Figure 34. APAC KRAS G12C Inhibitors Revenue 2021-2026 ($ millions)
Figure 35. Europe KRAS G12C Inhibitors Sales 2021-2026 (K Units)
Figure 36. Europe KRAS G12C Inhibitors Revenue 2021-2026 ($ millions)
Figure 37. Middle East & Africa KRAS G12C Inhibitors Sales 2021-2026 (K Units)
Figure 38. Middle East & Africa KRAS G12C Inhibitors Revenue 2021-2026 ($ millions)
Figure 39. Americas KRAS G12C Inhibitors Sales Market Share by Country in 2026
Figure 40. Americas KRAS G12C Inhibitors Revenue Market Share by Country (2021-2026)
Figure 41. Americas KRAS G12C Inhibitors Sales Market Share by Type (2021-2026)
Figure 42. Americas KRAS G12C Inhibitors Sales Market Share by Application (2021-2026)
Figure 43. United States KRAS G12C Inhibitors Revenue Growth 2021-2026 ($ millions)
Figure 44. Canada KRAS G12C Inhibitors Revenue Growth 2021-2026 ($ millions)
Figure 45. Mexico KRAS G12C Inhibitors Revenue Growth 2021-2026 ($ millions)
Figure 46. Brazil KRAS G12C Inhibitors Revenue Growth 2021-2026 ($ millions)
Figure 47. APAC KRAS G12C Inhibitors Sales Market Share by Region in 2026
Figure 48. APAC KRAS G12C Inhibitors Revenue Market Share by Region (2021-2026)
Figure 49. APAC KRAS G12C Inhibitors Sales Market Share by Type (2021-2026)
Figure 50. APAC KRAS G12C Inhibitors Sales Market Share by Application (2021-2026)
Figure 51. China KRAS G12C Inhibitors Revenue Growth 2021-2026 ($ millions)
Figure 52. Japan KRAS G12C Inhibitors Revenue Growth 2021-2026 ($ millions)
Figure 53. South Korea KRAS G12C Inhibitors Revenue Growth 2021-2026 ($ millions)
Figure 54. Southeast Asia KRAS G12C Inhibitors Revenue Growth 2021-2026 ($ millions)
Figure 55. India KRAS G12C Inhibitors Revenue Growth 2021-2026 ($ millions)
Figure 56. Australia KRAS G12C Inhibitors Revenue Growth 2021-2026 ($ millions)
Figure 57. China Taiwan KRAS G12C Inhibitors Revenue Growth 2021-2026 ($ millions)
Figure 58. Europe KRAS G12C Inhibitors Sales Market Share by Country in 2026
Figure 59. Europe KRAS G12C Inhibitors Revenue Market Share by Country (2021-2026)
Figure 60. Europe KRAS G12C Inhibitors Sales Market Share by Type (2021-2026)
Figure 61. Europe KRAS G12C Inhibitors Sales Market Share by Application (2021-2026)
Figure 62. Germany KRAS G12C Inhibitors Revenue Growth 2021-2026 ($ millions)
Figure 63. France KRAS G12C Inhibitors Revenue Growth 2021-2026 ($ millions)
Figure 64. UK KRAS G12C Inhibitors Revenue Growth 2021-2026 ($ millions)
Figure 65. Italy KRAS G12C Inhibitors Revenue Growth 2021-2026 ($ millions)
Figure 66. Russia KRAS G12C Inhibitors Revenue Growth 2021-2026 ($ millions)
Figure 67. Middle East & Africa KRAS G12C Inhibitors Sales Market Share by Country (2021-2026)
Figure 68. Middle East & Africa KRAS G12C Inhibitors Sales Market Share by Type (2021-2026)
Figure 69. Middle East & Africa KRAS G12C Inhibitors Sales Market Share by Application (2021-2026)
Figure 70. Egypt KRAS G12C Inhibitors Revenue Growth 2021-2026 ($ millions)
Figure 71. South Africa KRAS G12C Inhibitors Revenue Growth 2021-2026 ($ millions)
Figure 72. Israel KRAS G12C Inhibitors Revenue Growth 2021-2026 ($ millions)
Figure 73. Turkey KRAS G12C Inhibitors Revenue Growth 2021-2026 ($ millions)
Figure 74. GCC Countries KRAS G12C Inhibitors Revenue Growth 2021-2026 ($ millions)
Figure 75. Manufacturing Cost Structure Analysis of KRAS G12C Inhibitors in 2026
Figure 76. Manufacturing Process Analysis of KRAS G12C Inhibitors
Figure 77. Industry Chain Structure of KRAS G12C Inhibitors
Figure 78. Channels of Distribution
Figure 79. Global KRAS G12C Inhibitors Sales Market Forecast by Region (2027-2032)
Figure 80. Global KRAS G12C Inhibitors Revenue Market Share Forecast by Region (2027-2032)
Figure 81. Global KRAS G12C Inhibitors Sales Market Share Forecast by Type (2027-2032)
Figure 82. Global KRAS G12C Inhibitors Revenue Market Share Forecast by Type (2027-2032)
Figure 83. Global KRAS G12C Inhibitors Sales Market Share Forecast by Application (2027-2032)
Figure 84. Global KRAS G12C Inhibitors Revenue Market Share Forecast by Application (2027-2032)
